BioBuzz

We're thrilled to announce that the BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has maintained its impressive #3 ranking in Genetic Engineering & Biotechnology News Top U.S. Biopharma Clusters for 2024. This recognition highlights our region’s continued strength and innovation in the biopharma sector, marked by major investments from companies like QIAGEN and AstraZeneca, and substantial NIH funding. Despite some challenges, our ecosystem remains a powerhouse in patents, lab space, and venture capital. Congratulations to everyone contributing to this remarkable achievement! Read more by visiting: https://lnkd.in/ewppRdch #BioHealthCapitalRegion #Biopharma #Innovation #GEN #Healthcare #LifeSciences h/t Alex Philippidis

TEDCO announces a recent investment in Solaxa Inc. which includes State Small Business Credit Initiative (SSBCI) funding. The Maryland-based biopharmaceutical company is working to develop treatments for individuals suffering from neurodegenerative diseases and acute nerve injuries. Learn more about this investment at https://lnkd.in/ekzXmUHV #entrepreneur #Maryland #venturecapital Katherine Hill Ritchie Cassy Haber DeJonna Farrar Rachael Kalinyak Jack Miner Christian Walker Troy Stovall Maryland Marketing Partnership (MMP) U.S. Department of the Treasury #SSBCI Montgomery County Economic Development Corporation - Maryland Samantha Asker

Hula Therapeutics just won a $250,000 investment at the Pennsylvania Biotechnology Center’s 10th Annual Entrepreneur Spotlight! 🎉 Powered by Hatch BioFund, this victory marks a significant milestone in their journey to develop groundbreaking therapies for solid tumors. Read more: https://lnkd.in/eDP6h4SB #Biotech #Innovation #Startups #PABC #HatchBioFund #Healthcare #Entrepreneurship

John McLaughlin, a rising senior at Ohio University studying Chemical and Biomolecular Engineering, discovered his passion for biotechnology. This summer, he’s interning at Kymanox, where he's gaining hands-on experience in drug development and FDA approval processes. Kymanox has played a pivotal role in solidifying his passion and preparing him for his career. Read more: https://lnkd.in/eNHH7Ev4 #Biotechnology #Kymanox #Innovation

Did you know that drug overdose is now the third leading cause of death for U.S. adolescents? To tackle this challenge, a recent concept accepted by the advisory council of the The National Institute on Drug Abuse (NIDA), has inspired the FDA-funded Alliance for Pediatric Device Innovation (APDI), led by Children's National Hospital, to open an RFP seeking proposals from device innovators to develop medical devices to monitor, diagnose and treat youth suffering from substance use disorder and addiction.   In addition to receiving funding from APDI, successful applicants will receive technical assistance from The National Institute on Drug Abuse (NIDA) and prepare for the agency’s funding opportunities on this topic. Learn more and submit a grant application today. Don’t delay—the deadline is July 30, 2024. https://lnkd.in/eYjt-z-N cc: Beth Wells Kolaleh Eskandanian, PhD, MBA, PMP The National Institute on Drug Abuse (NIDA) Leonardo M. Angelone Michael Wolfson Youseph Yazdi Julia Finkel Francesca (Dolcimascolo) Joseph, MD, MBA Juliana Perl Children's National Hospital Michael Anderson, MD, MBA Meghan Delaney, DO, MPH John Konsin Ken Nelson Andrey Ostrovsky, MD, FAAP Anna Dunn

Formal announcement coming soon BUT the first #CHARM (Capital Health and mid-Atlantic Regenerative Medicine) event will be on July 31st at noon EST: The CHARMing Webinar series. Register below for FREE. Drs Catherine Bollard from Children's National Hospital and Will Eyestone from Revivicor, Inc. will both present updates on their work related to cell and gene therapy and regenerative medicine. https://lnkd.in/esEmRbxE

Come join the conversation around emerging methods and compelling applications of spatial biology in discovery immunology, translational medicine, and biomarker development at the BioTrac Spatial Biology Meeting Sept 9-10 in Germantown, MD!